MannKind Corp (MNKD)
4.62
+0.15
(+3.36%)
USD |
NASDAQ |
Mar 18, 16:00
4.66
+0.04
(+0.87%)
After-Hours: 20:00
MannKind Price: 4.62 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 4.46 | 4.74 | 4.41 | 4.62 | 2.531M |
Mar 15, 2024 | 4.46 | 4.57 | 4.404 | 4.47 | 5.811M |
Mar 14, 2024 | 4.54 | 4.64 | 4.435 | 4.50 | 2.433M |
Mar 13, 2024 | 4.44 | 4.61 | 4.44 | 4.59 | 3.144M |
Mar 12, 2024 | 4.58 | 4.64 | 4.40 | 4.45 | 3.357M |
Mar 11, 2024 | 5.25 | 5.26 | 4.55 | 4.61 | 6.830M |
Mar 08, 2024 | 5.20 | 5.40 | 5.185 | 5.27 | 5.134M |
Mar 07, 2024 | 4.85 | 5.21 | 4.80 | 5.15 | 8.675M |
Mar 06, 2024 | 4.85 | 4.86 | 4.71 | 4.80 | 4.733M |
Mar 05, 2024 | 4.65 | 4.86 | 4.61 | 4.75 | 6.435M |
Mar 04, 2024 | 4.60 | 4.67 | 4.46 | 4.65 | 6.870M |
Mar 01, 2024 | 4.15 | 4.695 | 4.15 | 4.50 | 7.006M |
Feb 29, 2024 | 4.03 | 4.32 | 3.98 | 4.11 | 6.371M |
Feb 28, 2024 | 3.90 | 4.28 | 3.864 | 3.92 | 6.239M |
Feb 27, 2024 | 3.60 | 3.83 | 3.57 | 3.78 | 3.338M |
Feb 26, 2024 | 3.57 | 3.58 | 3.47 | 3.58 | 1.731M |
Feb 23, 2024 | 3.58 | 3.60 | 3.525 | 3.55 | 1.449M |
Feb 22, 2024 | 3.60 | 3.635 | 3.53 | 3.59 | 1.176M |
Feb 21, 2024 | 3.61 | 3.64 | 3.53 | 3.60 | 1.205M |
Feb 20, 2024 | 3.59 | 3.66 | 3.56 | 3.60 | 1.511M |
Feb 16, 2024 | 3.71 | 3.72 | 3.62 | 3.65 | 1.497M |
Feb 15, 2024 | 3.62 | 3.74 | 3.60 | 3.71 | 2.865M |
Feb 14, 2024 | 3.45 | 3.61 | 3.412 | 3.60 | 2.371M |
Feb 13, 2024 | 3.60 | 3.60 | 3.38 | 3.40 | 3.025M |
Feb 12, 2024 | 3.51 | 3.68 | 3.43 | 3.67 | 2.793M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.8415
Minimum
Mar 16 2020
6.135
Maximum
Feb 19 2021
3.222
Average
3.65
Median
Feb 01 2021
Price Benchmarks
United Therapeutics Corp | 234.00 |
Corcept Therapeutics Inc | 24.31 |
Cassava Sciences Inc | 21.26 |
Amphastar Pharmaceuticals Inc | 42.85 |
Cogent Biosciences Inc | 6.74 |
Price Related Metrics
PS Ratio | 6.519 |
Earnings Yield | -0.87% |
Market Cap | 1.249B |
Operating PE Ratio | 122.44 |